| Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity CW Li, SO Lim, W Xia, HH Lee, LC Chan, CW Kuo, KH Khoo, SS Chang, ... Nature communications 7, 12632, 2016 | 1035 | 2016 |
| CHOP is involved in endoplasmic reticulum stress-induced apoptosis by enhancing DR5 expression in human carcinoma cells H Yamaguchi, HG Wang Journal of Biological Chemistry 279 (44), 45495-45502, 2004 | 966 | 2004 |
| PARP inhibitor upregulates PD-L1 expression and enhances cancer-associated immunosuppression S Jiao, W Xia, H Yamaguchi, Y Wei, MK Chen, JM Hsu, JL Hsu, WH Yu, ... Clinical Cancer Research 23 (14), 3711-3720, 2017 | 931 | 2017 |
| ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation JY Yang, CS Zong, W Xia, H Yamaguchi, Q Ding, X Xie, JY Lang, CC Lai, ... Nature cell biology 10 (2), 138-148, 2008 | 824 | 2008 |
| Deubiquitination and stabilization of PD-L1 by CSN5 SO Lim, CW Li, W Xia, JH Cha, LC Chan, Y Wu, SS Chang, WC Lin, ... Cancer Cell 30 (6), 925-939, 2016 | 710 | 2016 |
| Epithelial–mesenchymal transition induced by TNF-α requires NF-κB–mediated transcriptional upregulation of Twist1 CW Li, W Xia, L Huo, SO Lim, Y Wu, JL Hsu, CH Chao, H Yamaguchi, ... Cancer research 72 (5), 1290-1300, 2012 | 548 | 2012 |
| Eradication of triple-negative breast cancer cells by targeting glycosylated PD-L1 CW Li, SO Lim, EM Chung, YS Kim, AH Park, J Yao, JH Cha, W Xia, ... Cancer Cell 33 (2), 187-201. e10, 2018 | 539 | 2018 |
| The protein kinase PKB/Akt regulates cell survival and apoptosis by inhibiting Bax conformational change H Yamaguchi, HG Wang Oncogene 20 (53), 7779-7786, 2001 | 524 | 2001 |
| A perspective on anti-EGFR therapies targeting triple-negative breast cancer K Nakai, MC Hung, H Yamaguchi American journal of cancer research 6 (8), 1609, 2016 | 376 | 2016 |
| Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B L Fuino, P Bali, S Wittmann, S Donapaty, F Guo, H Yamaguchi, HG Wang, ... Molecular cancer therapeutics 2 (10), 971-984, 2003 | 358 | 2003 |
| Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics H Yamaguchi, JM Hsu, WH Yang, MC Hung Nature Reviews Clinical Oncology, 1-19, 2022 | 332 | 2022 |
| Regulation and Role of EZH2 in Cancer H Yamaguchi, MC Hung Cancer research and treatment: official journal of Korean Cancer Association …, 2014 | 331 | 2014 |
| Lipidic pore formation by the concerted action of proapoptotic BAX and tBID O Terrones, B Antonsson, H Yamaguchi, HG Wang, J Liu, RM Lee, ... Journal of Biological Chemistry 279 (29), 30081-30091, 2004 | 289 | 2004 |
| Nuclear trafficking of the epidermal growth factor receptor family membrane proteins YN Wang, H Yamaguchi, JM Hsu, MC Hung Oncogene 29 (28), 3997, 2010 | 271 | 2010 |
| Blocking c-Met–mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors Y Du, H Yamaguchi, Y Wei, JL Hsu, HL Wang, YH Hsu, WC Lin, WH Yu, ... Nature medicine 22 (2), 194, 2016 | 250 | 2016 |
| TYRO3 induces anti–PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis Z Jiang, SO Lim, M Yan, JL Hsu, J Yao, Y Wei, SS Chang, H Yamaguchi, ... Journal of Clinical Investigation 131 (8), e139434, 2021 | 239 | 2021 |
| Loss of Bif-1 suppresses Bax/Bak conformational change and mitochondrial apoptosis Y Takahashi, M Karbowski, H Yamaguchi, A Kazi, J Wu, SM Sebti, ... Molecular and cellular biology 25 (21), 9369-9382, 2005 | 232 | 2005 |
| Activity of suberoylanilide hydroxamic Acid against human breast cancer cells with amplification of her-2 P Bali, M Pranpat, R Swaby, W Fiskus, H Yamaguchi, M Balasis, K Rocha, ... Clinical cancer research 11 (17), 6382-6389, 2005 | 225 | 2005 |
| Molecular Cloning and Characterization of Bif-1 A NOVEL Src HOMOLOGY 3 DOMAIN-CONTAINING PROTEIN THAT ASSOCIATES WITH Bax SM Cuddeback, H Yamaguchi, K Komatsu, T Miyashita, M Yamada, C Wu, ... Journal of Biological Chemistry 276 (23), 20559-20565, 2001 | 210 | 2001 |
| Bax plays a pivotal role in thapsigargin-induced apoptosis of human colon cancer HCT116 cells by controlling Smac/Diablo and Omi/HtrA2 release from mitochondria H Yamaguchi, K Bhalla, HG Wang Cancer research 63 (7), 1483-1489, 2003 | 189 | 2003 |
